Trial Profile
A Longitudinal, Observational, Prospective Study to Evaluate the Autoimmunity in Psoriasis Patients Treated with Ustekinumab
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Ustekinumab (Primary)
- Indications Psoriasis
- Focus Adverse reactions; Pharmacodynamics
- 11 Dec 2015 New trial record